AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18294998 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K antagonists (adjusted-dose, target INR 2-3)
Number of subjects: 4576
Study 16943482 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally-invasive direct anterior approach
Number of subjects: 26
Study 16943482 — intervention group
Group type: COMPARATOR
Intervention: Anterolateral transgluteal approach
Number of subjects: 26
Study 12641543 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 5‐ASA 2 g and 80 mM L‐1 sodium‐butyrate bid (Group A)
Number of subjects: 51
Study 12641543 — intervention group
Group type: COMPARATOR
Intervention: 5‐ASA 2 g and 80 mL saline bid (Group B)
Number of subjects: 51
Study 10637255 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE chemotherapy every 2 weeks with G-CSF support
Number of subjects: 403
Study 10637255 — intervention group
Group type: COMPARATOR
Intervention: ACE chemotherapy every 3 weeks (control group)
Number of subjects: 403
Study 9051172 — intervention group
Group type: EXPERIMENTAL
Intervention: Palumbo 'Dynamic Patellar Brace'
Number of subjects: 59
Study 9051172 — intervention group
Group type: EXPERIMENTAL
Intervention: Cho‐Pat Knee Strap
Number of subjects: 59
Study 9051172 — intervention group
Group type: COMPARATOR
Intervention: No brace
Number of subjects: 59
Study 7908879 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 14
Study 7908879 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine
Number of subjects: 14
Study 7908879 — intervention group
Group type: COMPARATOR
Intervention: Control (no H2 receptor antagonist)
Number of subjects: 14
Study 29758356 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectation plus conditioning (E+C)
Number of subjects: 133
Study 29758356 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectation only (E‐only)
Number of subjects: 133
Study 29758356 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning only (C‐only)
Number of subjects: 133
Study 29758356 — intervention group
Group type: COMPARATOR
Intervention: Natural history (NH) control group
Number of subjects: 133
Study 29094434 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based autonomy supports for 12 weeks
Number of subjects: 71
Study 29094434 — intervention group
Group type: COMPARATOR
Intervention: Individual consultations on healthy lifestyle
Number of subjects: 71
Study 26076136 — intervention group
Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13)
Number of subjects: 0
Study 26076136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23841945 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) supplementation
Number of subjects: 153
Study 23841945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study 19777535 — intervention group
Group type: EXPERIMENTAL
Intervention: Telecare management for pain and depression
Number of subjects: 405
Study 18820040 — intervention group
Group type: EXPERIMENTAL
Intervention: Flip-flops
Number of subjects: 10
Study 18820040 — intervention group
Group type: COMPARATOR
Intervention: Athletic shoes
Number of subjects: 10
Study 18820040 — intervention group
Group type: EXPERIMENTAL
Intervention: Bare feet
Number of subjects: 10
Study 16417414 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioavailable testosterone
Number of subjects: 623
Study 16417414 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex hormone-binding globulin (SHBG)
Number of subjects: 623
Study 16417414 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone
Number of subjects: 623
Study 16417414 — intervention group
Group type: EXPERIMENTAL
Intervention: SHBG and bioavailable testosterone (in the same model)
Number of subjects: 623
Study 16417414 — intervention group
Group type: EXPERIMENTAL
Intervention: Other sex steroid levels (estrone, total estradiol, total testosterone)
Number of subjects: 623
Study 12716250 — intervention group
Group type: EXPERIMENTAL
Intervention: THC (delta‐9‐tetrahydrocannabinol) up to 10 mg/day for 6 weeks
Number of subjects: 24
Study 12716250 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 10793162 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilation with lower tidal volumes (initial tidal volume of 6 ml per kilogram of predicted body weight, plateau pressure of 30 cm of water or less)
Number of subjects: 861
Study 10793162 — intervention group
Group type: COMPARATOR
Intervention: Traditional ventilation treatment (initial tidal volume of 12 ml per kilogram of predicted body weight, plateau pressure of 50 cm of water or less)
Number of subjects: 861
Study 9489309 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac (30 mg i.v.) administered immediately after induction and for postoperative analgesia beginning at skin closure
Number of subjects: 40
Study 9489309 — intervention group
Group type: COMPARATOR
Intervention: No ketorolac administered before the operation, postoperative treatment same as intervention group
Number of subjects: 40
Study 22290668 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg caffeine in de-caffeinated coffee
Number of subjects: 48
Study 22290668 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-course meal (∼ 1300 calories)
Number of subjects: 48
Study 22290668 — intervention group
Group type: COMPARATOR
Intervention: Control group (no caffeine, no meal)
Number of subjects: 48
Study 3899404 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 254
Study 3899404 — intervention group
Group type: COMPARATOR
Intervention: Dipyridamole-aspirin
Number of subjects: 254
Study 3899404 — intervention group
Group type: COMPARATOR
Intervention: Pentoxifylline-aspirin
Number of subjects: 254
Study 31465307 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) performed twice daily for 4 weeks starting 3 days after surgery
Number of subjects: 0
Study 31465307 — intervention group
Group type: COMPARATOR
Intervention: IMT placebo group (IMT-PG)
Number of subjects: 0
Study 29504328 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8mg intravenously preoperatively and second dose 4 hours postoperatively
Number of subjects: 60
Study 29504328 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study 26827617 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback-incentive (monthly letter with social norm feedback plus small financial incentive for increasing green purchases)
Number of subjects: 2672
Study 26827617 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback-only (monthly letter with social norm feedback about healthy food purchases)
Number of subjects: 2672
Study 26827617 — intervention group
Group type: COMPARATOR
Intervention: Control (no contact)
Number of subjects: 2672
Study 26827617 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback-incentive
Number of subjects: 2672
Study 25113814 — intervention group
Group type: EXPERIMENTAL
Intervention: InsuPad
Number of subjects: 20
Study 22693239 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO‐PRO solution (1.2 g CHO/kg body mass and 0.4 g PRO/kg body mass)
Number of subjects: 11
Study 22693239 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO‐PRO solution
Number of subjects: 11
Study 22693239 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution (CON)
Number of subjects: 11
Study 19897389 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 10
Study 19897389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 18375410 — intervention group
Group type: EXPERIMENTAL
Intervention: Diane(35) Diario (35 mg ethinyl-estradiol plus 2 mg cyproterone acetate)
Number of subjects: 40
Study 18375410 — intervention group
Group type: COMPARATOR
Intervention: Metformin (850 mg twice daily)
Number of subjects: 40
Study 11672911 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 884
Study 11672911 — intervention group
Group type: EXPERIMENTAL
Intervention: DTP vaccination
Number of subjects: 884
Study 11672911 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive tuberculin reaction
Number of subjects: 884
Study 11672911 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination before last DTP vaccine
Number of subjects: 884
Study 11672911 — intervention group
Group type: EXPERIMENTAL
Intervention: Sick children
Number of subjects: 884
Study 11672911 — intervention group
Group type: EXPERIMENTAL
Intervention: Rainy season
Number of subjects: 884
Study 11672911 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimalarials within last week
Number of subjects: 884
Study 11672911 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination before 1 month of age
Number of subjects: 884
Study 9129845 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical data (history of myocardial infarction, pathological Q‐wave in resting ECG, systolic blood pressure at maximal exercise, degree of mitral regurgitation)
Number of subjects: 663
Study 9129845 — intervention group
Group type: COMPARATOR
Intervention: Exercise test results
Number of subjects: 663
Study 7961349 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy received by 65% of abused children for an average of 9 months.
Number of subjects: 84
Study 7961349 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 84
Study 7961349 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-esteem, depression, and behavior scores of abused children.
Number of subjects: 84
Study 7961349 — intervention group
Group type: EXPERIMENTAL
Intervention: Family dysfunction assessment.
Number of subjects: 84
Study 3298694 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus Calmette-Guerin therapy with quarterly maintenance instillations
Number of subjects: 42
Study 3298694 — intervention group
Group type: COMPARATOR
Intervention: Bacillus Calmette-Guerin therapy without maintenance instillations
Number of subjects: 42
Study 3298694 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance bacillus Calmette-Guerin therapy
Number of subjects: 42
Study 29603537 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist-to-height ratio (WHtR)
Number of subjects: 11125
Study 29603537 — intervention group
Group type: COMPARATOR
Intervention: Body mass index (BMI)
Number of subjects: 11125
Study 29603537 — intervention group
Group type: COMPARATOR
Intervention: Waist circumference
Number of subjects: 11125
Study 29603537 — intervention group
Group type: COMPARATOR
Intervention: Waist hip ratio (WHR)
Number of subjects: 11125
Study 27840413 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-Low-Calorie Diet (VLCD; 500 kcal/day) for 5 weeks
Number of subjects: 53
Study 27840413 — intervention group
Group type: COMPARATOR
Intervention: Low-Calorie Diet (LCD; 1250 kcal/day) for 12 weeks
Number of subjects: 53
Study 27840413 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of VLCD and LCD during the dietary intervention (DI) period
Number of subjects: 53
Study 27840413 — intervention group
Group type: EXPERIMENTAL
Intervention: VLCD during the WL period and DI period
Number of subjects: 53
Study 26329352 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive nebulization of acetylcysteine and salbutamol
Number of subjects: 950
Study 26329352 — intervention group
Group type: COMPARATOR
Intervention: Nebulization of acetylcysteine and/or salbutamol on indication
Number of subjects: 950
Study 23132658 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath holding (BH) duration
Number of subjects: 96
Study 23132658 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported intolerance of smoking abstinence
Number of subjects: 96
Study 21167334 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet function monitoring with dose adjustment in suboptimal responders
Number of subjects: 2466
Study 21167334 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of dual antiplatelet therapy beyond 1 year
Number of subjects: 2466
Study 21167334 — intervention group
Group type: COMPARATOR
Intervention: Standard of care without monitoring and without dose adjustment
Number of subjects: 2466
Study 18391346 — intervention group
Group type: EXPERIMENTAL
Intervention: Haptic training
Number of subjects: 0
Study 18391346 — intervention group
Group type: COMPARATOR
Intervention: Visual training
Number of subjects: 0
Study 17184230 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoridated dentifrice preceded by calcium lactate rinse
Number of subjects: 16
Study 17184230 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo dentifrice preceded by calcium lactate rinse
Number of subjects: 16
Study 17184230 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoridated dentifrice preceded by deionized water prerinse
Number of subjects: 16
Study 17184230 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo dentifrice preceded by deionized water prerinse
Number of subjects: 16
Study 17184230 — intervention group
Group type: COMPARATOR
Intervention: Calcium lactate prerinse
Number of subjects: 16
Study 14870949 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA 75 mg
Number of subjects: 12
Study 14870949 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol 0.5 g/kg
Number of subjects: 12
Study 14870949 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 10929961 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mm diagnostic sheath (Group 1)
Number of subjects: 362
Study 10929961 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mm sheath with paracervical block (Group 2)
Number of subjects: 362
Study 10929961 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5 mm sheath (Group 3)
Number of subjects: 362
Study 10929961 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracervical block (Group 2)
Number of subjects: 362
Study 10929961 — intervention group
Group type: COMPARATOR
Intervention: Comparison of pain scores across groups
Number of subjects: 362
Study 9039228 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy alone (extended fields, 4500 cGy)
Number of subjects: 39
Study 9039228 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy plus adjuvant chemotherapy (cyclophosphamide, vincristine and prednisone)
Number of subjects: 39
Study 1357681 — intervention group
Group type: EXPERIMENTAL
Intervention: CGP 361 A (beta-blocking drug)
Number of subjects: 0
Study 1357681 — intervention group
Group type: EXPERIMENTAL
Intervention: Flupenthixol (low-dose neuroleptic)
Number of subjects: 0
Study 1357681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29990442 — intervention group
Group type: COMPARATOR
Intervention: Dietary modification (group D)
Number of subjects: 48
Study 29990442 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training and dietary modification (group DE)
Number of subjects: 48
Study 29934046 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (0.5, 1, and 2 g daily)
Number of subjects: 60
Study 29934046 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 29934046 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation
Number of subjects: 60
Study 27239991 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoflavin (2 tabs. 2 times a day for 25 days) + cognitive therapy
Number of subjects: 103
Study 25151398 — intervention group
Group type: EXPERIMENTAL
Intervention: Benson's relaxation response technique (2-week intervention)
Number of subjects: 0
Study 25151398 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study 21667181 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-bundle ACL reconstruction
Number of subjects: 60
Study 21667181 — intervention group
Group type: COMPARATOR
Intervention: Double-bundle ACL reconstruction
Number of subjects: 60
Study 19116781 — intervention group
Group type: EXPERIMENTAL
Intervention: FOYC (Focus on Youth in the Caribbean)
Number of subjects: 1360
Study 18403130 — intervention group
Group type: EXPERIMENTAL
Intervention: Socially evaluated cold-pressor test (SECPT)
Number of subjects: 70
Study 18403130 — intervention group
Group type: COMPARATOR
Intervention: Standard cold-pressor test (CPT)
Number of subjects: 70
Study 18403130 — intervention group
Group type: COMPARATOR
Intervention: Social evaluation during hand immersion in warm water
Number of subjects: 70
Study 15721098 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher initial resting ventricular rate (IRVR)
Number of subjects: 4059
Study 15721098 — intervention group
Group type: COMPARATOR
Intervention: Adequate rate control
Number of subjects: 4059
Study 12860497 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine 24 mg/d
Number of subjects: 459
Study 12860497 — intervention group
Group type: COMPARATOR
Intervention: Placebo followed by Galantamine 24 mg/d
Number of subjects: 459
Study 10100083 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 90
Study 10100083 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 90
Study 8655703 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-tube nested PCR
Number of subjects: 2033
Study 2004540 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid formulation (1.67 mg/ml)
Number of subjects: 24
Study 2004540 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg tablet (2 x 200 mg)
Number of subjects: 24
Study 2004540 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg tablet
Number of subjects: 24
Study 6439360 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (200, 400, 600, and 800 mg)
Number of subjects: 20
Study 6439360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31369593 — intervention group
Group type: EXPERIMENTAL
Intervention: oXiris filter
Number of subjects: 16
Study 31369593 — intervention group
Group type: COMPARATOR
Intervention: standard filter
Number of subjects: 16
Study 29454514 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent linsitinib (600mg once daily on Days 1-3 per week) with paclitaxel (80mg/m2 on Days 1, 8, and 15)
Number of subjects: 152
Study 29454514 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous linsitinib (150mg twice daily) with paclitaxel (80mg/m2 on Days 1, 8, and 15)
Number of subjects: 152
Study 29454514 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel alone
Number of subjects: 152
Study 26857248 — intervention group
Group type: EXPERIMENTAL
Intervention: Balneotherapy (BT) in addition to physical therapy (PT)
Number of subjects: 60
Study 26857248 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy (PT) alone
Number of subjects: 60
Study 24172160 — intervention group
Group type: EXPERIMENTAL
Intervention: Levomilnacipran ER 75 or 100 mg/day
Number of subjects: 75
Study 22038336 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL)
Number of subjects: 13
Study 22038336 — intervention group
Group type: COMPARATOR
Intervention: CNI
Number of subjects: 13
Study 19270108 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant! decision aid
Number of subjects: 395
Study 19270108 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 395
Study 17311014 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacy technician‐led medication review and counselling clinic
Number of subjects: 0
Study 15637232 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium intake
Number of subjects: 0
Study 11593218 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-minute adenosine infusion at 140 microg/kg per minute
Number of subjects: 599
Study 11593218 — intervention group
Group type: COMPARATOR
Intervention: 6-minute adenosine infusion at 140 microg/kg per minute
Number of subjects: 599
Study 9638504 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine clonixinate (125 mg tablet every 4 h for 2 days)
Number of subjects: 151
Study 9638504 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol/codeine (500 mg + 30 mg every 4 h for 2 days)
Number of subjects: 151
Study 9638504 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol/codeine (500 mg + 30 mg)
Number of subjects: 151
Study 9638504 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine clonixinate (125 mg)
Number of subjects: 151
Study 8206470 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% clindamycin vaginal cream
Number of subjects: 55
Study 8206470 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 2492462 — intervention group
Group type: EXPERIMENTAL
Intervention: Oximetrix Opticath (flow-directed PA catheter utilizing reflective fiberoptic oximetry for continuous Sv‐O2 monitoring)
Number of subjects: 99
Study 2492462 — intervention group
Group type: COMPARATOR
Intervention: Edwards quadruple‐lumen flow‐directed PA catheter
Number of subjects: 99
Study 2492462 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed venous oximetry
Number of subjects: 99
Study 1138844 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Diamox with variable doses of Pilocarpine
Number of subjects: 0
Study 31627057 — intervention group
Group type: EXPERIMENTAL
Intervention: Less tight control (target diastolic BP 100 mmHg)
Number of subjects: 987
Study 31627057 — intervention group
Group type: COMPARATOR
Intervention: Tight control (target diastolic BP 85 mmHg)
Number of subjects: 987
Study 31627057 — intervention group
Group type: EXPERIMENTAL
Intervention: Less tight control
Number of subjects: 987
Study 31627057 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 987
Study 27299461 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulization of Shenmai Injection (0.6 mL/kg in 10 mL normal saline)
Number of subjects: 38
Study 27299461 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous drip of Shenmai Injection (0.6 mL/kg dissolved in 250 mL of 10% glucose)
Number of subjects: 38
Study 27299461 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NS) control group (equal volume given intravenously)
Number of subjects: 38
Study 25424589 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study 25424589 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine
Number of subjects: 60
Study 23141748 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 0
Study 23141748 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21192206 — intervention group
Group type: EXPERIMENTAL
Intervention: Appreciative Inquiry (AI) quality improvement strategy
Number of subjects: 30
Study 18652328 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming-removing obstruction needling method
Number of subjects: 62